Finasteride is a 5-alpha reductase inhibitor that blocks the conversion of testosterone to dihydrotestosterone (DHT) — the primary androgen driving androgenetic alopecia (male pattern baldness). FDA-approved since 1997, finasteride reduces scalp DHT by approximately 70% at the standard 1mg daily dose, making it the most effective oral treatment for hair loss available.
Finasteride selectively inhibits Type II 5-alpha reductase, the enzyme responsible for converting testosterone to dihydrotestosterone (DHT) in the scalp, prostate, and liver. DHT is the primary culprit in androgenetic alopecia — it binds to androgen receptors in genetically susceptible hair follicles, causing miniaturization and eventual loss. By blocking DHT production, finasteride halts this process.
Finasteride is a competitive inhibitor of Type II 5α-reductase with ~100x selectivity over Type I. This isoenzyme predominates in the scalp and prostate. 1mg daily reduces serum DHT by ~70% and scalp DHT by similar amounts.
With reduced DHT exposure, susceptible follicles stop miniaturizing. Existing terminal hairs are preserved, and some vellus hairs may regain terminal characteristics — explaining the regrowth seen in clinical trials.
Lower DHT levels extend the anagen (growth) phase of the hair cycle. This results in longer, thicker hairs and delayed entry into the catagen/telogen phases where shedding occurs.
Blocking conversion to DHT causes a ~10-15% increase in serum testosterone. This is generally not clinically significant but partially offsets the reduced androgenic activity from lower DHT.
The pivotal trials for finasteride 1mg (Propecia) were conducted by Merck in the 1990s, involving over 1,500 men with androgenetic alopecia. Results were assessed using hair counts, investigator assessments, and patient self-evaluation. The data below represents findings from the original Phase 3 trials and subsequent long-term follow-up studies.
💊 Key finding: At 2 years, 83% of men on finasteride maintained or increased hair count vs. 28% on placebo. 66% showed visible regrowth assessed by investigators.
Finasteride is available in two FDA-approved formulations: 1mg (Propecia) for androgenetic alopecia and 5mg (Proscar) for benign prostatic hyperplasia (BPH). For hair loss, the standard dose is 1mg daily, though some practitioners prescribe lower doses or alternate-day regimens to minimize side effects while maintaining efficacy.
The established dose for androgenetic alopecia. Taken once daily with or without food.
Some studies suggest 0.2mg may retain ~80% of efficacy with potentially fewer side effects.
Every-other-day dosing may maintain efficacy due to long tissue half-life while reducing systemic exposure.
Topical formulations (0.1–0.25%) reduce systemic absorption while maintaining scalp DHT inhibition.
⏳ Timeline: Expect initial results (reduced shedding) at 3-4 months. Visible improvement typically begins at 6 months. Maximum benefit is reached at 12-24 months of continuous use. Stopping finasteride reverses gains within 6-12 months as DHT returns to baseline.
Finasteride is the most effective oral hair loss treatment, but it works through a different mechanism than minoxidil. Understanding these differences helps optimize treatment strategy.
🔄 Combination therapy: Finasteride + minoxidil is the gold standard for aggressive hair loss. Finasteride halts progression by blocking DHT; minoxidil stimulates growth independently. Studies show superior results with combination therapy vs. either agent alone.
Sexual side effects are the primary concern with finasteride. The incidence in clinical trials was low — slightly above placebo — and most cases resolved after discontinuation. The controversial "post-finasteride syndrome" (PFS) describes persistent symptoms after stopping, but controlled studies have not confirmed its existence or mechanism.
⚠️ Post-Finasteride Syndrome (PFS): Some men report persistent sexual dysfunction, depression, and cognitive effects after stopping finasteride. PFS is recognized by some regulatory agencies but not definitively proven in controlled studies. If you experience persistent symptoms, discontinue and consult a physician. The existence and mechanism of PFS remain controversial.
Finasteride has been FDA-approved for over 25 years with a well-established safety profile in millions of patients.
Propecia (1mg): Approved December 1997 for androgenetic alopecia in men. Not approved for women due to teratogenic risk (feminization of male fetuses).
Proscar (5mg): Approved June 1992 for benign prostatic hyperplasia. Often cut into pieces for cost-effective hair loss treatment (off-label).
Generic availability: Finasteride is available as a generic in the US since 2006. Cost is typically $10-30/month vs. $70+ for brand Propecia.
Kaufman KD, et al. "Finasteride in the treatment of men with androgenetic alopecia." J Am Acad Dermatol 1998;39:578-589. N=1,553 men. 83% maintained or increased hair count at 2 years.
PubMed: 9777765 →Roberts JL, et al. "Clinical dose-ranging studies with finasteride." Eur J Dermatol 2006;16:293-298. 90% of men who responded at year 1 maintained improvement at 5 years.
PubMed: 16935794 →Rossi A, et al. "Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups." J Am Acad Dermatol 2011;65:1023-1027. Long-term safety and efficacy data.
PubMed: 21835045 →Leyden J, et al. "Finasteride in the treatment of men with frontal male pattern hair loss." J Am Acad Dermatol 1999;40:930-937. Established 1mg as optimal dose.
PubMed: 10570373 →Piraccini BM, et al. "Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia." J Am Acad Dermatol 2022;86:1096-1101. Demonstrates efficacy with reduced systemic absorption.
PubMed: 35053530 →Hu R, et al. "Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia." Indian J Dermatol Venereol Leprol 2015;81:268-274. Superior results with combination.
PubMed: 25852139 →Complementary products for hair loss treatment protocols.
Affiliate links help support MeetPeptide at no extra cost to you.
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
⚕️ Medical Disclaimer: This page is for educational and informational purposes only. It is not medical advice. Finasteride is a prescription medication. Never self-prescribe. Always consult with a qualified healthcare provider — ideally a dermatologist — before starting any hair loss treatment. All data sourced from published peer-reviewed research with PubMed citations provided.